|
|
||||||||
From the Hamilton Glaucoma Center and Department of Ophthalmology, University of California San Diego, La Jolla, California.
| Abstract |
|---|
|
|
|---|
METHODS. Aqueous humor dynamics of NIH Swiss White mouse were assessed with an injection and aspiration system, using fine glass microneedles. Intraocular pressure (IOP) was measured by a microneedle connected to a pressure transducer. Episcleral venous pressure (EVP) was measured by gradually lowering intracameral pressure until blood reflux into Schlemms canal was observed. Outflow facility (C) was determined based on constant pressure perfusion measurements obtained at two different IOPs. Aqueous volume (Va) was determined by direct measurement of aspirated aqueous humor. Aqueous humor production (Fa) was measured by the dilution method with rhodamine-dextran. Conventional and uveoscleral outflow (Fc and Fu, respectively), as well as the turnover rate of aqueous humor, were also calculated.
RESULTS. IOP and EVP were 15.7 ± 2.0 and 9.5 ± 1.2 mm Hg, respectively (n = 20). Fa was 0.18 ± 0.05 µL/min (mean ± SD; n = 8). C was 0.0051 ± 0.0006 µL/min per mm Hg (n = 8). Estimated Fc and Fu were 0.032 and 0.148 µL/min, respectively. Fc was 18% of Fa. Fu was 82% of Fa. Va was 5.9 ± 0.5 µL (n = 8). The calculated turnover rate of aqueous humor was 2.5%.
CONCLUSIONS. The mouse eye has similar aqueous production and aqueous humor turnover rate as the human eye. The presence of both conventional and uveoscleral outflow suggests that the mouse is a useful model system for further investigations of the biology of aqueous dynamics.
In general, the smaller the eye size, the more difficult it has been to obtain measurements of aqueous humor dynamics using conventional methods. Because of their small eyes, it has been particularly difficult to assess aqueous dynamics in the mouse. To the best of our knowledge, a comprehensive description of aqueous humor dynamics in the mouse has not been performed. Hence, it is still unknown whether the aqueous humor dynamics of the mouse eye are similar to the human eye. To clarify the mechanisms of IOP regulation in the mouse, it is necessary to have a better understanding of the aqueous humor dynamics. In view of these observations, the present study was undertaken to measure aqueous humor dynamic parameters, including outflow facility, aqueous volume, and aqueous humor production, in the NIH Swiss white mouse.
| Materials and Methods |
|---|
|
|
|---|
Anesthesia
The mice were anesthetized by intraperitoneal injection of a mixture of ketamine (100 mg/kg, Ketaset; Fort Dodge Animal Health, Fort Dodge, IA) and xylazine (9 mg/kg, TranquiVed; VEDCO Inc., St. Joseph, MO) prepared at room temperature. Animals were gently restrained (Decapicone; Braintree Scientific Inc., Braintree, MA) to avoid stress, and anesthesia was administered with a 30-gauge needle. Each mouse was monitored carefully to assess the state of anesthesia. If the mouse did not respond to pinching of the back skin, it was placed on the platform for IOP measurement and procedures for evaluating aqueous humor dynamics.
Instrument System
Two microneedles made of borosilicate glass (100-µm tip diameter and 1.0-mm outer diameter, World Precision Instruments [WPI], Sarasota, FL) were used to make the aqueous dynamics measurements as shown in Figure 1 . Both microneedles were mounted on micromanipulators. One microneedle was connected to a pressure transducer (Model BLPR; WPI). A silicon tube (0.38 mm inner diameter) linked the transducer to a fluid reservoir filled with physiological saline (BSS Plus; Alcon, Fort Worth, TX) for the measurement of episcleral venous pressure (EVP) and outflow facility (C). Alternatively, the reservoir was filled with 70 kDa rhodamine-dextran (RD; Molecular Probes, Eugene, OR) diluted in physiological saline for the measurement of aqueous humor production. Its height could be varied to modulate intracameral pressure. The system pressure detected by the transducer was recorded by computer (Chart software; ADInstruments, Colorado Springs, CO), as described previously.14 This infusion system was used to measure IOP, EVP, and C as described later.
|
Intraocular Pressure Measurement
IOP was measured with an infusion system described previously (n = 20).14
EVP Measurement
Before the measurement of aqueous humor production, EVP was measured using only the infusion system (n = 20). Intracameral pressure was gradually decreased until there was an observable reflux of blood within Schlemms canal from the episcleral vein. The intracameral pressure at which reflux began was designated EVP. To obtain this measurement, the stopcock between the pressure transducer and the infusion tube was closed, the microneedle was inserted into the anterior chamber, and the baseline IOP was measured. Next, the height of the saline reservoir was adjusted to equalize the tubing pressure with IOP. After the stopcock was opened, the height of the reservoir was lowered at a rate of 0.5 mm Hg (0.68 cm H2O height)/min. As IOP became equal to EVP, there was reflux of blood from collector channels into Schlemms canal. While carefully monitoring the limbus under the microscope, we recorded the pressure at which the reflux of blood was first observed and designated it the EVP. After the first measurement, the reservoir was returned to the original height (the baseline IOP). The measurement procedure was repeated in the same eye for a total of three determinations.
Determination of Outflow Facility
The infusion system was used to determine the outflow facility (C; Fig. 1 ). All fluid within the infusion system was replaced with physiological saline. The measurement was based on measuring total outflow volume (Vt; in microliters) for a specific time (in this study, 10 minutes) at two different levels of IOPt, as described previously.10 After insertion of the infusion needle into the anterior chamber, the reservoir height was controlled to maintain IOP at 25 mmHg. After verification of IOP stability, the initial fluid level in the silicon tube was marked. After a 10-minute interval, the new fluid level was marked. The total amount of infused fluid was noted as the infused volume at 25 mm Hg (Vt=25). Next, IOP was increased to 35 mm Hg and the 10-minute infused volume (Vt=35) was also measured in the same eye. Because total outflow is equivalent to aqueous humor production (Fa in microliters per minute), Fa also can be represented as the sum of conventional outflow (Fc,t in microliters per minute) and uveoscleral outflow (Fu in microliters per minute),
![]() | (1) |
![]() | (2) |
![]() | (3) |
![]() | (4) |
![]() | (5) |
![]() | (6) |
![]() | (7) |
Aqueous Humor Production
Aqueous humor production (Fa in microliters per minute) was determined by measuring dilution of an infusion solution (0.5 µg/mL 70 kDa RD in physiological saline; BSS Plus; Alcon) as it was slowly perfused through the anterior chamber (n = 8).10 13 RD at 70 kDa was used as a tracer because there is minimal loss of this molecule by diffusion.16 Pilot studies established that the optimal perfusion rate and time for the mouse eye were 3 µL/min and 20 minutes, respectively. If the perfusion rate was faster, it was difficult to detect the difference of tracer concentration between in- and outflowing perfusion fluids. In contrast, prior studies in rat eyes indicate that slower rates with longer durations can lead to alteration of aqueous humor production and disruption of the bloodaqueous barrier.10 To conduct measurement of Fa, EVP was first measured as described earlier, and then the height of the reservoir was adjusted to equalize the system pressure to EVP. Next, the aspiration needle was inserted into the anterior chamber, as illustrated in Figure 1 . This needle was used to collect the perfusion outflow fluid. Care was taken that neither microneedle touched the iris. The micropump connected to the aspiration needle maintained the perfusion rate at 3 µL/min. Because the perfusion pressure was maintained at EVP according to the height of the fluid surface in the reservoir, pressure-dependent outflow was reduced to zero. The tubing connecting the aspiration needle to the micropump was marked every 52.9 mm to facilitate collection of 6-µL samples (0.38 mm inner diameter x 52.9 mm = 6 µL). After 20 minutes of perfusion, the perfused fluid was retrieved from the 264.5-mm segment of the tubing closest to the microneedle. This tubing segment was cut into five equal pieces (corresponding to 6 µL for each piece and totalling 30 µL). Thus, these five collected samples contained the perfusion outflow fluid that had been collected every 2 minutes during the prior 10-minute perfusion time. This strategy avoided collecting fluid during the first 10 minutes because of the possibility that the ratio of tracer to aqueous humor was not yet stable during this period. Division of the fluid collected during the final 10 minutes of the perfusion allowed confirmation that the dilution of the perfusion fluid by physiological aqueous outflow had reached a steady state.
Measurement of RD and Calculation of Fa
RD concentration was determined with a spectrofluorometer (Model SFM25; Kontron, Zürich, Switzerland). The excitation and emission wavelengths were 550 and 580 nm, respectively. The concentration of RD in the injection fluid (Ci) was measured five times and averaged. The concentration of RD in the five collected samples (Co) was measured and divided by Ci. The mean value of Co/Ci in each eye (n = 8) was used to calculate Fa according to the following rationale. The total amount of RD the perfusion inflow fluid and the perfusion outflow fluid in a specific time are equal. Hence, the concentration of RD in the perfusion inflow fluid (Ci) multiplied by the rate of the perfusion inflow (vi) is equal to the concentration of RD in the perfusion outflow fluid (Co) multiplied by flow rate of perfusion outflow fluid (vo)
![]() | (8) |
![]() | (9) |
![]() | (10) |
![]() | (11) |
![]() | (12) |
![]() | (13) |
![]() | (14) |
Determination of Conventional and Uveoscleral Outflow
IOP, EVP, and C were measured and averaged. Using these data, the conventional outflow was calculated as
![]() | (15) |
![]() | (16) |
![]() | (17) |
Determination of Aqueous Humor Volume and Turnover Rate of Aqueous Fluid
Va was measured by the aspirated volume of aqueous fluid, using the aspiration system. In nontreated mouse eyes (n = 8), the saline-filled aspiration needle was inserted into the anterior chamber. Aspiration of the aqueous humor (100 nL/sec) began, with the anterior segment observed under a microscope. Apposition of the central edge of the iris to the cornea was the endpoint of the aspiration. The total aspirated volume was indicated on the micropump display. The turnover rate of aqueous fluid was calculated as
![]() | (18) |
Aqueous Humor Protein Concentration
Aqueous protein concentration was measured after measurement of EVP to determine whether microneedle penetration followed by alteration of IOP induced a significant breakdown in the bloodaqueous barrier. To prevent dilution of aqueous, a small volume of mineral oil was aspirated into the needle tip before insertion to separate the aqueous humor from the saline in the fluid column. After insertion of the microneedle, intracameral pressure was shifted from 16 to 8 mm Hg and then back to 16 mm Hg three times over the course of 6 minutes by raising and lowering the reservoir connected to the microneedle. Immediately after this procedure, approximately 4 µL of aqueous humor was aspirated into the microneedle. Because the mineral oil in the needle tip may alter the accuracy of EVP measurement, the data obtained during this series of experiments were not included for determination of EVP. Approximately 4 µL of aqueous humor was aspirated from the contralateral control eyes to determine baseline protein concentration. The Bradford protein assay (Bio-Rad Laboratories, Hercules, CA) was used according to the manufacturers guidelines. The sensitivity of this assay was 2 µg/mL and the linear dynamic range extended to 50 µg/mL. Before evaluation in the assay, 1.5 µL of each aqueous sample was diluted to 100 µL. The assay was conducted in a microtiter plate, and absorption was measured at 595 nm with a microtiter plate reader (SpectraMax 250; Molecular Devices, Sunnyvale, CA). Aqueous protein concentration was determined based on linear regression analysis of a serial dilution of bovine serum albumin standards.
| Results |
|---|
|
|
|---|
|
|
| Discussion |
|---|
|
|
|---|
Several strengths of this experimental system are apparent. First, because all components of the experimental system used for IOP measurement were either glass or hard plastic, the influence of system compliance at physiological IOP was likely to be minimal. For the measurement of EVP and Fu, the tubing had an inside diameter of 0.38 mm and a total length less than 1 m. Hence, the volume of the tubing was less than 113 µL. Because the measurement system was open to the atmosphere, and system pressure in each case was regulated by the height of the water column, the effect of any tubing compliance on these measurements was eliminated. The effect of pipette resistance on the measurements was minimal, as pressure change associated with entry of our microneedle into the eye, as recorded at the transducer, appeared as a square-wave shift in pressure on the chart recording.14 This indicated there was rapid pressure equilibration within the microneedles. Finally, the stability of the aqueous humor protein concentration after microneedle insertion followed by raising and lowering intracameral pressure indicates that there was minimal disruption of the bloodaqueous barrier during the course of these aqueous dynamics measurements.
A limitation of this system is that anesthesia was used during the collection of the measurements. We have observed that between 4 and 8 minutes after administration of anesthesia, blood pressure was the same in anesthetized mice as in awake mice (Aihara M, Lindsey JD, Weinreb RN, unpublished observation, 2002). IOP is stable during the 4 to 8 minutes after administration of anesthesia.14 These data support the view that IOP and EVP measured during this period closely reflect IOP in the unanesthetized mouse. Future improvements in the accuracy of noninvasive methods to measure IOP18 without anesthesia, as well as development of noninvasive methods to assess other aqueous dynamics parameters in the awake mouse, would clarify this issue further.
The method for measurement of facility in the mouse eye was adapted from an established procedure for facility determination in rat eyes.10 Aqueous outflow in the mouse is difficult to measure accurately because the volume of aqueous outflow at normal IOP is small. If the pressure was increased to either 25 or 35 mm Hg and C remains constant, we reasoned that the volume of aqueous outflow would be greater; this would facilitate more accurate measurement of flow. However, it is possible that the measurement of facility in the present study was affected by the pressures used for the measurements. Grierson and Lee observed structural abnormalities in trabecular outflow tissues of Rhesus monkeys with experimental increases of intraocular pressure to 50 mm Hg that were not seen at 15, 22, and 30 mm Hg.19 20 They also observed minor changes in the lysosomal system of monkey trabecular meshwork cells at 30 mm Hg that were not observed at 15 and 22 mm Hg.19 21
The calculations used for our method depend on measuring aqueous humor production (Fa) by a modified dilution method in which pressure-dependent outflow (Fc) was minimized by setting IOP at the same level as EVP. An alternate method to determine Fa would be to measure the dilution of a perfusate after it has passed through the anterior chamber. The following equation rigorously describes the relationship between dye concentration in the inflow solution (Ci) and outflow solutions during perfusion (Co, Cu, and Cc corresponding to the outflow cannula fluid, fluid exiting by uveoscleral outflow, and fluid exiting by conventional outflow, respectively):
![]() |
![]() |
With the perfusion method used in previous studies in the monkey1 2 8 and rat,10 Cu and Cc were assumed to be equal to Co. Thus, this formula was reduced to
![]() |
![]() |
Aqueous volume was measured by direct collection of aqueous humor from the anterior chamber, the posterior chamber fluid, and possibly even some vitreous. The use of this aqueous volume to calculate the turnover rate is likely to be appropriate because the intraocular humor is mainly aqueous fluid secreted by the ciliary body. It is possible that the anterior chamber is not completely empty when the central iris touches the cornea. Nevertheless, this is a reproducible and reasonable end point for this measurement.
Determination of uveoscleral outflow in small eyes has typically been difficult. Direct measurement of the distributed amount of tracer in ocular tissues and plasma, as assessed in monkey eyes, may be more accurate than indirect methods.7 8 This procedure is complicated and applicable only to larger animal eyes or to human donor eyes obtained at autopsy. In smaller eyes, precise separation of ocular tissues and recovery of a tracer is more difficult. Uveoscleral outflow was indirectly calculated with the Goldmann equation, using the measured EVP in the present study. However, it is not known whether uveoscleral outflow in the mouse eye is independent of pressure. Further investigations are needed to clarify this issue.
Our data demonstrate that mouse eye has aqueous humor dynamics similar to those in human eyes with respect to IOP, EVP, and turnover rate. 22 23 Moreover, direct measurement of EVP by cannulation of the episcleral veins in the rabbit eye also obtained a pressure measurement essentially the same as in the present study (9.6 mm Hg).24 The aqueous humor turnover rate of the mouse eye (2.5%) also was similar to that of the rat eye (2.23%).10 This observation roughly corroborates the theory that the turnover rate is uniform at approximately 1.5% of total aqueous volume even though the aqueous humor volume varies among species.25 However, in our study, the aqueous volume includes the posterior chamber volume. If the mouse aqueous volume is underestimated, however, the turnover rate may be overestimated. The physiological presence of both conventional and uveoscleral outflow pathways in mouse is consistent with morphologic demonstration of the presence of these pathways.17 26 27 The present results indicate that there is a larger proportion of uveoscleral outflow in the mouse than in the monkey.2
The mouse is a useful model to investigate ocular diseases because of the availability of transgenic mice, their similar genetic background, relatively quick breeding, and low cost.28 Moreover, mouse and human eyes have similar anatomic structure, outflow pathways, and response to IOP-lowering drugs.14 17 Hence, pharmacological studies using various transgenic mice should facilitate molecular analysis of the mechanism of IOP reduction. However, these studies necessitate determination of aqueous dynamics for each tested mouse strain, as normal IOP can vary substantially among them.26
In conclusion, the results of this study now show that aqueous humor production and turnover in the mouse eye are similar to values reported for other species. Direct measurement of uveoscleral outflow is needed to confirm whether there is a larger proportion of uveoscleral outflow in the mouse than in the monkey. Regardless, the presence of both outflow pathways suggests that the mouse is a useful model system for further investigation of the biology of aqueous dynamics.
| Acknowledgements |
|---|
| Footnotes |
|---|
Submitted for publication May 21, 2003; revised July 8 and August 1, 2003; accepted August 11, 2003.
Disclosure: M. Aihara, None; J.D. Lindsey, None; R.N. Weinreb, None
The publication costs of this article were defrayed in part by page charge payment. This article must therefore be marked "advertisement" in accordance with 18 U.S.C.
1734 solely to indicate this fact.
Corresponding author: Robert N. Weinreb, Hamilton Glaucoma Center, University of California San Diego, 9500 Gilman Drive, La Jolla, CA 92093-0946; weinreb{at}eyecenter.ucsd.edu
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
Y. X. Kong, J. G. Crowston, A. J. Vingrys, I. A. Trounce, and B. V. Bui Functional Changes in the Retina during and after Acute Intraocular Pressure Elevation in Mice Invest. Ophthalmol. Vis. Sci., December 1, 2009; 50(12): 5732 - 5740. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Dai, J. D. Lindsey, X. Duong-Polk, D. Nguyen, A. Hofer, and R. N. Weinreb Outflow Facility in Mice with a Targeted Type I Collagen Mutation Invest. Ophthalmol. Vis. Sci., December 1, 2009; 50(12): 5749 - 5753. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Saeki, T. Ota, M. Aihara, and M. Araie Effects of Prostanoid EP Agonists on Mouse Intraocular Pressure Invest. Ophthalmol. Vis. Sci., May 1, 2009; 50(5): 2201 - 2208. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhang, B. R. Davidson, W. D. Stamer, J. K. Barton, L. Y. Marmorstein, and A. D. Marmorstein Enhanced Inflow and Outflow Rates Despite Lower IOP in Bestrophin-2-Deficient Mice Invest. Ophthalmol. Vis. Sci., February 1, 2009; 50(2): 765 - 770. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Bakall, P. McLaughlin, J. B. Stanton, Y. Zhang, H. C. Hartzell, L. Y. Marmorstein, and A. D. Marmorstein Bestrophin-2 Is Involved in the Generation of Intraocular Pressure Invest. Ophthalmol. Vis. Sci., April 1, 2008; 49(4): 1563 - 1570. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. Crowston, C. A. Morris, J. D. Lindsey, and R. N. Weinreb Prostaglandin FP Receptors Do Not Contribute to 24-hour Intraocular Pressure Variation in Mice Invest. Ophthalmol. Vis. Sci., May 1, 2007; 48(5): 2095 - 2098. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Zhong, J. Bradley, W. Schubert, E. Ahmed, A. P. Adamis, D. T. Shima, G. S. Robinson, and Y.-S. Ng Erythropoietin Promotes Survival of Retinal Ganglion Cells in DBA/2J Glaucoma Mice Invest. Ophthalmol. Vis. Sci., March 1, 2007; 48(3): 1212 - 1218. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. Fautsch, D. H. Johnson, and the Second ARVO/Pfizer Research Institute Working Aqueous humor outflow: what do we know? Where will it lead us? Invest. Ophthalmol. Vis. Sci., October 1, 2006; 47(10): 4181 - 4187. [Full Text] [PDF] |
||||
![]() |
J. G. Crowston, J. D. Lindsey, C. A. Morris, L. Wheeler, F. A. Medeiros, and R. N. Weinreb Effect of Bimatoprost on Intraocular Pressure in Prostaglandin FP Receptor Knockout Mice Invest. Ophthalmol. Vis. Sci., December 1, 2005; 46(12): 4571 - 4577. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Ota, H. Murata, E.-i. Sugimoto, M. Aihara, and M. Araie Prostaglandin Analogues and Mouse Intraocular Pressure: Effects of Tafluprost, Latanoprost, Travoprost, and Unoprostone, Considering 24-Hour Variation Invest. Ophthalmol. Vis. Sci., June 1, 2005; 46(6): 2006 - 2011. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Zillig, A. Wurm, F. J. Grehn, P. Russell, and E. R. Tamm Overexpression and Properties of Wild-Type and Tyr437His Mutated Myocilin in the Eyes of Transgenic Mice Invest. Ophthalmol. Vis. Sci., January 1, 2005; 46(1): 223 - 234. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. Crowston, J. D. Lindsey, M. Aihara, and R. N. Weinreb Effect of Latanoprost on Intraocular Pressure in Mice Lacking the Prostaglandin FP Receptor Invest. Ophthalmol. Vis. Sci., October 1, 2004; 45(10): 3555 - 3559. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. Crowston, M. Aihara, J. D. Lindsey, and R. N. Weinreb Effect of Latanoprost on Outflow Facility in the Mouse Invest. Ophthalmol. Vis. Sci., July 1, 2004; 45(7): 2240 - 2245. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Mabuchi, J. D. Lindsey, M. Aihara, M. R. Mackey, and R. N. Weinreb Optic Nerve Damage in Mice with a Targeted Type I Collagen Mutation Invest. Ophthalmol. Vis. Sci., June 1, 2004; 45(6): 1841 - 1845. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |